Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to learn whether certain methods of detecting awareness in vegetative or minimally conscious patients (using neuroimaging) are sensitive to the effects of psilocybin...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Western University, Canada
NCT07277309 · Consciousness Disorders, Disorders of Consciousness Due to Severe Brain Injury
NCT07228286 · Disorders of Consciousness
NCT06939348 · Consciousness Disorders, Disorders of Consciousness Due to Severe Brain Injury
NCT06323031 · Disorders of Consciousness
NCT06851156 · Disorders of Consciousness, Severe Brain Injury, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions